CARE TWENTYONE CORPORATION
TSE Standard
¥402.00
-2.43%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Has paid a dividend in each of the last 5 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 5.91 is above 1.
- Return on equity is on the lower side at 8.4%.
- Return on capital employed is on the lower side at 4.3%.
- Net profit margin is slim at 0.8%.
- Profit growth has been slow over five years (about -20% a year).
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
1.81
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Computed without the market-value term.
Piotroski F-ScoreModerate
5 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap¥54億
Current Price¥ 402.00
High / Low¥ 613.00 / 390.00
Stock P/E51.27551
Book Value¥ 327.36
Dividend Yield2.43%
ROCE4.26%
ROE8.40%
Debt to Equity5.91
Current Ratio1.05
P/B Ratio1.3053856
EPS¥ 28.45
PAT Margin0.80%
ICR1.61
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity